{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-05T14:07:50.051471+00:00","company":{"ticker":"PROK","cik":1850270,"company_name":"PROKIDNEY CORP."},"pagination":{"limit":100,"returned":9,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"governance_change","fact_key":"172cc17d53dfd3c8bc59fdada4daf9773a7c0ea4","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2025-07-16T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Adoption of new Bylaws in connection with domestication from Cayman Islands to Delaware."},"claim":"PROKIDNEY CORP.: Adoption of new Bylaws in connection with domestication from Cayman Islands to Delaware.","evidence_excerpt":"ProKidney Delaware adopted a certificate of incorporation (the “Certificate of Incorporation”) and bylaws (the “Bylaws”), and the rights of holders of the Common Stock are now governed by such documents and the DGCL.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-25-026049","anchor_url":"https://secwatch.observer/filing/0001140361-25-026049#claim-172cc17d53dfd3c8bc59fdada4daf9773a7c0ea4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125026049/0001140361-25-026049-index.htm"},{"fact_type":"governance_change","fact_key":"81d4ea5c2e3f1b987aa4c574d960730a0f785518","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2025-07-16T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Adoption of new Certificate of Incorporation in connection with domestication from Cayman Islands to Delaware."},"claim":"PROKIDNEY CORP.: Adoption of new Certificate of Incorporation in connection with domestication from Cayman Islands to Delaware.","evidence_excerpt":"ProKidney Delaware adopted a certificate of incorporation (the “Certificate of Incorporation”) and bylaws (the “Bylaws”), and the rights of holders of the Common Stock are now governed by such documents and the DGCL.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-25-026049","anchor_url":"https://secwatch.observer/filing/0001140361-25-026049#claim-81d4ea5c2e3f1b987aa4c574d960730a0f785518","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125026049/0001140361-25-026049-index.htm"},{"fact_type":"governance_change","fact_key":"b8063f064ed5e306558ae3d75ebf4a00f6f688d0","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2025-07-03T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Adopted new Bylaws in connection with Domestication from Cayman Islands to Delaware."},"claim":"PROKIDNEY CORP.: Adopted new Bylaws in connection with Domestication from Cayman Islands to Delaware.","evidence_excerpt":"The Certificate of Incorporation and Bylaws were effective as of the Domestication Date.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-25-024839","anchor_url":"https://secwatch.observer/filing/0001140361-25-024839#claim-b8063f064ed5e306558ae3d75ebf4a00f6f688d0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125024839/0001140361-25-024839-index.htm"},{"fact_type":"governance_change","fact_key":"b5c980a5ff8f6e6f8631b84585ce7099e0960c22","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2025-07-03T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Adopted new Certificate of Incorporation in connection with Domestication from Cayman Islands to Delaware."},"claim":"PROKIDNEY CORP.: Adopted new Certificate of Incorporation in connection with Domestication from Cayman Islands to Delaware.","evidence_excerpt":"The Certificate of Incorporation and Bylaws were effective as of the Domestication Date.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-25-024839","anchor_url":"https://secwatch.observer/filing/0001140361-25-024839#claim-b5c980a5ff8f6e6f8631b84585ce7099e0960c22","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125024839/0001140361-25-024839-index.htm"},{"fact_type":"earnings_release","fact_key":"fa6ee748f98eed67dfd2d733db8dedd601cd0eae","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2024-05-10T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the first quarter ended March 31, 2024","report_date":"2024-05-10","result_type":"reported_results","revenue_text":null},"claim":"PROKIDNEY CORP. reported financial results for the first quarter ended March 31, 2024.","evidence_excerpt":"On May 10, 2024, ProKidney Corp. issued a press release to announce its financial results for the quarter ended March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-057443","anchor_url":"https://secwatch.observer/filing/0000950170-24-057443#claim-fa6ee748f98eed67dfd2d733db8dedd601cd0eae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024057443/0000950170-24-057443-index.htm"},{"fact_type":"executive_change","fact_key":"ed3d595bc9","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2024-03-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-03-25","interim":false,"role":"Executive Vice President, Technical Operations","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Ulrich Ernst was appointed as Executive Vice President, Technical Operations at PROKIDNEY CORP..","evidence_excerpt":"On March 25, 2024, ProKidney Corp. (the “Company”) announced the appointment of Ulrich Ernst, Ph.D. as the Company’s Executive Vice President, Technical Operations effective as of March 25, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-035914","anchor_url":"https://secwatch.observer/filing/0000950170-24-035914#claim-ed3d595bc9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024035914/0000950170-24-035914-index.htm"},{"fact_type":"earnings_release","fact_key":"c04f632151e1e25eed8d48a3d3f5ad3c3e9041cc","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2024-03-22T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the year ended December 31, 2023","report_date":"2024-03-21","result_type":"reported_results","revenue_text":null},"claim":"PROKIDNEY CORP. reported financial results for the year ended December 31, 2023.","evidence_excerpt":"ProKidney Corp. issued a press release to announce its financial results for the year ended December 31, 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-034961","anchor_url":"https://secwatch.observer/filing/0000950170-24-034961#claim-c04f632151e1e25eed8d48a3d3f5ad3c3e9041cc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024034961/0000950170-24-034961-index.htm"},{"fact_type":"executive_change","fact_key":"39340ab7a4","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2024-03-18T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-03-13","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Deepak Jain resigned as Chief Operating Officer at PROKIDNEY CORP..","evidence_excerpt":"On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Jain.","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0000950170-24-032827","anchor_url":"https://secwatch.observer/filing/0000950170-24-032827#claim-39340ab7a4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032827/0000950170-24-032827-index.htm"},{"fact_type":"executive_change","fact_key":"db2f2857b5","cik":1850270,"ticker":"PROK","company_name":"PROKIDNEY CORP.","filed_at":"2024-03-18T23:59:59+00:00","payload":{"action":"separated","action_category":"departure","departure_tone":"routine","effective_date":"2024-03-13","interim":false,"role":null,"role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Dr. Bertram departed as ceo at PROKIDNEY CORP..","evidence_excerpt":"On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Bertram.","confidence":0.65,"filing_url":"https://secwatch.observer/filing/0000950170-24-032821","anchor_url":"https://secwatch.observer/filing/0000950170-24-032821#claim-db2f2857b5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032821/0000950170-24-032821-index.htm"}]}